July 9, 2020
Bloomberg Law
Pharmaceutical companies looking for the next blockbuster drug increasingly view patent litigators as a secret weapon at the bargaining table, proving their value to an industry built on intellectual property and dealmaking.
The trend of IP litigators as strategic business advisers has grown over the past decade, as brand-name drugmakers look to them for help in determining what types of deals to strike—acquire vs. partner vs. license—in a way that best dovetails with the pharmaceutical company’s own R&D and broader business interests.
Bloomberg Law contacted Finnegan attorney Brian Kacedon for his thoughts regarding the trend. He said, “When I first started practicing 20 years ago, it was very much like you were a patent prosecutor [writing patents] or you were a patent litigator. For the stuff in between, there were a lot of deal lawyers and there were people in-house. Outside counsel wasn’t doing that as much.” Acknowledging the trend to include IP lawyers in transactions was slow to take hold, Brian also pointed out, “If the most important part of the deal is really the intellectual property, then involving people who work on that issue day in and day out is really important.”
Read the full article here.
Award/Ranking
Managing IP Americas Awards 2024: Finnegan Shortlisted for Nine Awards, Including Firm of the Year
March 12, 2024
Commentary
February 29, 2024
Press Release
Finnegan Secures Another Patent Victory for BMW Group in the District of Delaware
February 27, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.